Log In
Print
BCIQ
Print
Print this Print this
 

BBI-4000

  Manage Alerts
Collapse Summary General Information
Company Brickell Biotech Inc.
DescriptionTopical soft anticholingeric
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationExcessive sweating
Indication DetailsTreat hyperhidrosis (excessive sweating)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today